International Cancer Benchmarking Partnership (ICBP)
Contact the ICBP team
If you have any views or comments about the partnership, we would like to hear from you.
Call for expressions of interest
We are looking to commission the most up to date cancer survival comparisons for lung, ovary, colon, rectum, liver, pancreas, oesophagus and stomach cancer across at least five countries.
The ICBP is also considering two supplementary analyses alongside the core survival benchmark:
- An overview of jurisdiction adherence to international coding frameworks, including staging classifications.
- Quantifying the impact of local registration practices on short-term cancer survival.
Expressions of interest are welcome for any of the above elements from teams, consortia or collaborations based anywhere in the world, with a range of experience and expertise including epidemiology, statistics, cancer data and policy research. Proposals to deliver any one – or multiple elements – of these three analyses are welcome.
The research brief containing detailed information around the benchmark and supplementary analyses can be found here.
Your expression of interest should be submitted to email@example.com no later than 5pm on Friday 6th November 2015 (GMT). Applicants whose proposals are within remit will be invited to submit a full project proposal to be received by 5pm on Friday 18th December 2015 (GMT).
ICBP is a unique and innovative global partnership of clinicians, academics and policymakers. It is the first of its kind, seeking to understand how and why cancer survival varies between countries/jurisdictions.
The partnership aims to generate insight and understanding that will help all partners improve cancer survival outcomes by optimising cancer policies and services. These insights are also likely to be relevant to other nations.